Literature DB >> 20602518

Impact of ultrafiltration and nanofiltration of an industrial fish protein hydrolysate on its bioactive properties.

Laurent Picot1, Rozenn Ravallec, Martine Fouchereau-Péron, Laurent Vandanjon, Pascal Jaouen, Maryse Chaplain-Derouiniot, Fabienne Guérard, Aurélie Chabeaud, Yves Legal, Oscar Martinez Alvarez, Jean-Pascal Bergé, Jean-Marie Piot, Irineu Batista, Carla Pires, Gudjon Thorkelsson, Charles Delannoy, Greta Jakobsen, Inez Johansson, Patrick Bourseau.   

Abstract

BACKGROUND: Numerous studies have demonstrated that in vitro controlled enzymatic hydrolysis of fish and shellfish proteins leads to bioactive peptides. Ultrafiltration (UF) and/or nanofiltration (NF) can be used to refine hydrolysates and also to fractionate them in order to obtain a peptide population enriched in selected sizes. This study was designed to highlight the impact of controlled UF and NF on the stability of biological activities of an industrial fish protein hydrolysate (FPH) and to understand whether fractionation could improve its content in bioactive peptides.
RESULTS: The starting fish protein hydrolysate exhibited a balanced amino acid composition, a reproducible molecular weight (MW) profile, and a low sodium chloride content, allowing the study of its biological activity. Successive fractionation on UF and NF membranes allowed concentration of peptides of selected sizes, without, however, carrying out sharp separations, some MW classes being found in several fractions. Peptides containing Pro, Hyp, Asp and Glu were concentrated in the UF and NF retentates compared to the unfractionated hydrolysate and UF permeate, respectively. Gastrin/cholecystokinin-like peptides were present in the starting FPH, UF and NF fractions, but fractionation did not increase their concentration. In contrast, quantification of calcitonin gene-related peptide (CGRP)-like peptides demonstrated an increase in CGRP-like activities in the UF permeate, relative to the starting FPH. The starting hydrolysate also showed a potent antioxidant and radical scavenging activity, and a moderate angiotensin-converting enzyme (ACE)-1 inhibitory activity, which were not increased by UF and NF fractionation.
CONCLUSION: Fractionation of an FPH using membrane separation, with a molecular weight cut-off adapted to the peptide composition, may provide an effective means to concentrate CGRP-like peptides and peptides enriched in selected amino acids. The peptide size distribution observed after UF and NF fractionation demonstrates that it is misleading to characterize the fractions obtained by membrane filtration according to the MW cut-off of the membrane only, as is currently done in the literature. Copyright (c) 2010 Society of Chemical Industry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20602518     DOI: 10.1002/jsfa.4020

Source DB:  PubMed          Journal:  J Sci Food Agric        ISSN: 0022-5142            Impact factor:   3.638


  15 in total

1.  Isolation and characterization of glycosylated neuropeptides.

Authors:  Yang Liu; Qinjingwen Cao; Lingjun Li
Journal:  Methods Enzymol       Date:  2019-08-12       Impact factor: 1.600

Review 2.  Production of Plant Proteases and New Biotechnological Applications: An Updated Review.

Authors:  Franco David Troncoso; Daniel Alberto Sánchez; María Luján Ferreira
Journal:  ChemistryOpen       Date:  2022-03       Impact factor: 2.630

3.  ACE inhibitory activity of pangasius catfish (Pangasius sutchi) skin and bone gelatin hydrolysate.

Authors:  Fatemeh Mahmoodani; Masomeh Ghassem; Abdul Salam Babji; Salma Mohamad Yusop; Roya Khosrokhavar
Journal:  J Food Sci Technol       Date:  2012-05-18       Impact factor: 2.701

4.  Elements for optimizing a one-step enzymatic bio-refinery process of shrimp cuticles: Focus on enzymatic proteolysis screening.

Authors:  R Baron; M Socol; R Kaas; A Arhaliass; J Rodriguez Del Pino; K Le Roux; C Donnay-Moreno; J P Bergé
Journal:  Biotechnol Rep (Amst)       Date:  2017-06-13

5.  Purification, Characterization and Evaluation of Inhibitory Mechanism of ACE Inhibitory Peptides from Pearl Oyster (Pinctada fucata martensii) Meat Protein Hydrolysate.

Authors:  Pengru Liu; Xiongdiao Lan; Muhammad Yaseen; Shanguang Wu; Xuezhen Feng; Liqin Zhou; Jianhua Sun; Anping Liao; Dankui Liao; Lixia Sun
Journal:  Mar Drugs       Date:  2019-08-08       Impact factor: 5.118

6.  In Vitro Bioactivity of Astaxanthin and Peptides from Hydrolisates of Shrimp (Parapenaeus longirostris) By-Products: From the Extraction Process to Biological Effect Evaluation, as Pilot Actions for the Strategy "From Waste to Profit".

Authors:  Concetta Maria Messina; Simona Manuguerra; Rosaria Arena; Giuseppe Renda; Giovanna Ficano; Mariano Randazzo; Stefano Fricano; Saloua Sadok; Andrea Santulli
Journal:  Mar Drugs       Date:  2021-04-13       Impact factor: 5.118

7.  A simple and convenient method for the preparation of antioxidant peptides from walnut (Juglans regia L.) protein hydrolysates.

Authors:  Ming-Chuan Liu; Sheng-Jie Yang; Da Hong; Jin-Ping Yang; Min Liu; Yun Lin; Chia-Hui Huang; Chao-Jih Wang
Journal:  Chem Cent J       Date:  2016-06-21       Impact factor: 4.215

8.  Identification and Molecular Docking Study of a Novel Angiotensin-I Converting Enzyme Inhibitory Peptide Derived from Enzymatic Hydrolysates of Cyclina sinensis.

Authors:  Fangmiao Yu; Zhuangwei Zhang; Liwang Luo; Junxiang Zhu; Fangfang Huang; Zuisu Yang; Yunping Tang; Guofang Ding
Journal:  Mar Drugs       Date:  2018-10-27       Impact factor: 5.118

9.  Microbiological Profile and Bioactive Properties of Insect Powders Used in Food and Feed Formulations.

Authors:  Concetta Maria Messina; Raimondo Gaglio; Maria Morghese; Marco Tolone; Rosaria Arena; Giancarlo Moschetti; Andrea Santulli; Nicola Francesca; Luca Settanni
Journal:  Foods       Date:  2019-09-09

10.  Valorization of Fish by-products: Purification of Bioactive Peptides from Codfish Blood and Sardine Cooking Wastewaters by Membrane Processing.

Authors:  Soudabeh Ghalamara; Sara Silva; Carla Brazinha; Manuela Pintado
Journal:  Membranes (Basel)       Date:  2020-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.